Gutiérrez, J. M. et al. Snakebite envenoming. Nat Rev Dis Primers 3, 1–21 (2017).
Kasturiratne, A. et al. The world burden of snakebite: a literature evaluation and modelling primarily based on regional estimates of envenoming and deaths. PLoS Med 5, 1591–1604 (2008).
Google Scholar
Longbottom, J. et al. Vulnerability to snakebite envenoming: a world mapping of hotspots. Lancet 392, 673–684 (2018).
Google Scholar
Waiddyanatha, S., Silva, A., Siribaddana, S. & Isbister, G. Ok. Long-term results of snake envenoming. Toxins 11, 1–13 (2019).
Google Scholar
Molyneux, D. H. The London declaration on uncared for tropical illnesses: 5 years on. Trans. R Soc. Trop. Med. Hyg. 110, 623–625 (2016).
Google Scholar
Annan, Ok. Snakebite: the largest public well being disaster you’ve by no means heard of. https://www.kofiannanfoundation.org/combatting-hunger/public-health-snakebite/ (2018).
Williams, D. J. et al. Strategy for a globally coordinated response to a precedence uncared for tropical illness: snakebite envenoming. PLoS Negl. Trop. Dis. 13, 1–12 (2019).
Google Scholar
Casewell, N. R., Jackson, T. N. W., Laustsen, A. H. & Sunagar, Ok. Causes and penalties of snake venom variation. Trends Pharmacol. Sci. 41, 570–581 (2020).
Google Scholar
Clare, R. H., Hall, S. R., Patel, R. N. & Casewell, N. R. Small molecule drug discovery for uncared for tropical snakebite. Trends Pharmacol. Sci. 42, 340–353 (2021).
Google Scholar
Tasoulis, T. & Isbister, G. Ok. A evaluation and database of snake venom proteomes. Toxins 9, 1–23 (2017).
Google Scholar
Slagboom, J., Kool, J., Harrison, R. A. & Casewell, N. R. Haemotoxic snake venoms: their useful exercise, influence on snakebite victims and pharmaceutical promise. Br. J. Haematol. 177, 947–959 (2017).
Google Scholar
Ferraz, C. R. et al. Multifunctional toxins in snake venoms and therapeutic implications: from ache to hemorrhage and necrosis. Front. Ecol. Evol. 7, 1–19 (2019).
Google Scholar
Gutiérrez, J. M., Escalante, T., Rucavado, A. & Herrera, C. Hemorrhage brought on by snake venom metalloproteinases: a journey of discovery and understanding. Toxins 8, 1–19 (2016).
Google Scholar
Ranawaka, U. Ok., Lalloo, D. G. & de Silva, H. J. Neurotoxicity in snakebite – the boundaries of our data. PLoS Negl. Trop. Dis. 7, 1–18 (2013).
Google Scholar
Fujioka, M. Skin necrosis as a consequence of snakebites. in Skin Necrosis (eds. Téot, L., Meaume, S., Ennis, W. & del Marmol, V.) 109–115 (Springer-Verlag Wien, 2015).
Chakrabarty, D. & Sarkar, A. Cytotoxic results of snake venoms. in Snake Venoms (eds. Gopalakrishnakone, P., Inagaki, H., Vogel, C.-W., Mukherjee, A. Ok. & Rahmy, T. R.) 1–16 (Springer, 2016).
Brown, N. & Landon, J. Antivenom: probably the most cost-effective therapy on the planet? Toxicon 55, 1405–1407 (2010).
Google Scholar
de Silva, H. A., Ryan, N. M. & de Silva, H. J. Adverse reactions to snake antivenom, and their prevention and therapy. Br. J. Clin. Pharmacol. 81, 446–452 (2016).
Google Scholar
Lalloo, D. G. & Theakston, R. D. G. Snake antivenoms. J. Toxicol. Clin. Toxicol. 41, 277–290 (2003).
Google Scholar
Harrison, R. A. et al. Preclinical antivenom-efficacy testing reveals probably disturbing deficiencies of snakebite therapy functionality in East Africa. PLoS Negl. Trop. Dis. 11, 1–24 (2017).
Google Scholar
Kini, R. M., Sidhu, S. S. & Laustsen, A. H. Biosynthetic oligoclonal antivenom (BOA) for snakebite and next-generation remedies for snakebite victims. Toxins 10, 1–10 (2018).
Google Scholar
Mao, Y. C. et al. Naja atra snakebite in Taiwan. Clin. Toxicol. 56, 273–280 (2017).
Google Scholar
Lin, C. C., Chaou, C. H. & Gao, S. Y. Influential elements of native tissue necrosis after Taiwan cobra bites: A secondary evaluation of the scientific significance of venom detection in sufferers of cobra snakebites. Toxins 13, 1–11 (2021).
Google Scholar
Rivel, M. et al. Pathogenesis of dermonecrosis induced by venom of the spitting cobra, Naja nigricollis: an experimental research in mice. Toxicon 119, 171–179 (2016).
Google Scholar
Liu, C. C. et al. Pathogenesis of native necrosis induced by Naja atra venom: Assessment of the neutralization skill of Taiwanese freeze-dried neurotoxic antivenom in animal fashions. PLoS Negl. Trop. Dis. 14, 1–20 (2020).
Google Scholar
Ferreira Junior, R. S. & Barraviera, B. Tissue necrosis after canine bothropic envenoming: a case report. J. Venom. Anim. Toxins 7, 302–312 (2001).
Google Scholar
Laustsen, A. H., Johansen, Ok. H., Engmark, M. & Andersen, M. R. Recombinant snakebite antivenoms: a cost-competitive resolution to a uncared for tropical illness? PLoS Negl. Trop. Dis. 11, 1–14 (2017).
Google Scholar
Laustsen, A. H. How can monoclonal antibodies be harnessed towards uncared for tropical illnesses and different infectious illnesses? Expert. Opin. Drug Discov. 14, 1103–1112 (2019).
Google Scholar
Lewin, M., Samuel, S., Merkel, J. & Bickler, P. Varespladib (LY315920) seems to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a doable pre-referral therapy for envenomation. Toxins 8, 1–16 (2016).
Google Scholar
Wang, Y. et al. Exploration of the inhibitory potential of varespladib for snakebite envenomation. Molecules 23, 1–13 (2018).
Layfield, H. J. et al. Repurposing most cancers medication batimastat and marimastat to inhibit the exercise of a gaggle I metalloprotease from the venom of the western diamondback rattlesnake, Crotalus atrox. Toxins 12, 1–17 (2020).
Google Scholar
Albulescu, L.-O. et al. Preclinical validation of a repurposed steel chelator as a community-based therapeutic for hemotoxic snakebite. Sci. Transl. Med. 12, 1–13 (2020).
Google Scholar
Albulescu, L.-O. et al. A therapeutic mixture of two small molecule toxin inhibitors offers broad preclinical efficacy towards viper snakebite. Nat. Commun. 11, 1–14 (2020).
Google Scholar
Xie, C. et al. Neutralizing results of small molecule inhibitors and steel chelators on coagulopathic Viperinae snake venom toxins. Biomedicines 8, 1–18 (2020).
Google Scholar
Bulfone, T. C., Samuel, S. P., Bickler, P. E. & Lewin, M. R. Developing small molecule therapeutics for the preliminary and adjunctive therapy of snakebite. J. Trop. Med. 2018, 1–10 (2018).
Google Scholar
Rucavado, A. et al. Inhibition of native hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa2EDTA. Am. J. Trop. Med. Hyg. 63, 313–319 (2000).
Google Scholar
Williams, D. et al. The world snake chew initiative: an antidote for snake chew. Lancet 375, 89–91 (2010).
Google Scholar
Williams, H. F. et al. The pressing must develop novel methods for the analysis and therapy of snakebites. Toxins 11, 1–29 (2019).
Google Scholar
Benson, H. A. E., Grice, J. E., Mohammed, Y., Namjoshi, S. & Roberts, M. S. Topical and transdermal drug supply: from easy potions to sensible applied sciences. Curr. Drug Deliv. 16, 444–460 (2019).
Google Scholar
Alkilani, A. Z., McCrudden, M. T. C. & Donnelly, R. F. Transdermal drug supply: Innovative pharmaceutical developments primarily based on disruption of the barrier properties of the stratum corneum. Pharmaceutics 7, 438–470 (2015).
Tiwari, N., Aggarwal, G., Jain, G. Ok. & Mittal, G. Multi-drug loaded microneedles for emergency therapy of snakebite envenomation. Med. Hypotheses 165, 1–7 (2022).
Google Scholar
Nicholls, S. J. et al. Varespladib and cardiovascular occasions in sufferers with an acute coronary syndrome: the VISTA-16 randomized scientific trial. J. Am. Med. Assoc. 311, 252–262 (2014).
Google Scholar
Winer, A., Adams, S. & Mignatti, P. Matrix metalloproteinase inhibitors in most cancers remedy: turning previous failures into future successes. Mol. Cancer Ther. 17, 1147–1155 (2018).
Google Scholar
Arias, A. S., Rucavado, A. & Gutiérrez, J. M. Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate native and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom. Toxicon 132, 40–49 (2017).
Google Scholar
Howes, J.-M., Theakston, R. D. G. & Laing, G. D. Neutralization of the haemorrhagic actions of viperine snake venoms and venom metalloproteinases utilizing artificial peptide inhibitors and chelators. Toxicon 49, 734–739 (2007).
Google Scholar
Bryan-Quirós, W., Fernández, J., Gutiérrez, J. M., Lewin, M. R. & Lomonte, B. Neutralizing properties of LY315920 towards snake venom group I and II myotoxic phospholipases A2. Toxicon 157, 1–7 (2019).
Google Scholar
Lewin, M. et al. Delayed Oral LY333013 Rescues Mice from Highly Neurotoxic, Lethal Doses of Papuan Taipan (Oxyuranus scutellatus) Venom. Toxins 10, 380 (2018).
Google Scholar
Lewin, M. et al. Delayed LY333013 (oral) and LY315920 (intravenous) reverse extreme neurotoxicity and rescue juvenile pigs from deadly doses of Micrurus fulvius(Eastern coral snake) venom. Toxins 10, 1–17 (2018).
Google Scholar
Gutiérrez, J. M., Lewin, M. R., Williams, D. J. & Lomonte, B. Varespladib (LY315920) and methyl varespladib (LY333013) abrogate or delay lethality induced by presynaptically appearing neurotoxic snake venoms. Toxins 12, 1–12 (2020).
Google Scholar
Mosmann, T. Rapid colorimetric assay for mobile progress and survival: utility to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55–63 (1983).
Google Scholar
Riss, T. L. et al. Cell viability assays [2016 edited version]. in Assay Guidance Manual (eds. Sittampalam, G. S. et al.) 295–320 (Eli Lilly & Company and the National Center for Advancing Translational Sciences, 2013).
Colombo, I. et al. HaCaT cells as a dependable in vitro differentiation mannequin to dissect the inflammatory/restore response of human keratinocytes. Mediat. Inflamm 2017, 1–12 (2017).
Google Scholar
Wilson, V. G. Growth and differentiation of HaCaT keratinocytes. Methods Mol. Biol. 1195, 33–41 (2014).
Google Scholar
Borkow, G., Gutiérrez, J. & Ovadia, M. In vitro exercise of BaH1, the principle hemorrhagic toxin of Bothrops asper snake venom on bovine endothelial cells. Toxicon 33, 1387–1391 (1995).
Google Scholar
Fallahi-Sichani, M., Honarnejad, S., Heiser, L. M., Gray, J. W. & Sorger, P. Ok. Metrics apart from efficiency reveal systematic variation in responses to most cancers medication. Nat. Chem. Biol. 9, 708–714 (2013).
Google Scholar
Black, J. A private view of pharmacology. Annu. Rev. Pharmacol. Toxicol. 36, 1–33 (1996).
Google Scholar
Hall, S. R. et al. A lipid-based oral complement protects pores and skin cells in tradition from ultraviolet gentle and prompts antioxidant and anti inflammatory mechanisms. J. Natural Health Product Res. 2, 1–14 (2020).
Google Scholar
Corkery, D. P., Dellaire, G. & Berman, J. N. Leukaemia xenotransplantation in zebrafish – chemotherapy response assay in vivo. Br. J. Haematol. 153, 786–789 (2011).
Google Scholar
Chiaraviglio, L. & Kirby, J. E. Evaluation of impermeant, DNA-binding dye fluorescence as a real-time readout of eukaryotic cell toxicity in a excessive throughput screening format. Assay Drug Dev. Technol. 12, 219–228 (2014).
Google Scholar
Chitolie, M. S. & Toescu, E. C. High-throughput methodology for dynamic measurements of mobile viability utilizing a FLUOstar OPTIMA. BMG LABTECH vol. 04 1–2 https://www.bmglabtech.com/high-throughput-method-for-dynamic-measurements-of-cellular-viability-using-a-bmg-labtech-microplate-reader/ (2008).
Theakston, R. D. & Reid, H. A. Development of easy customary assay procedures for the characterization of snake venom. Bull World Health Organ 61, 949–956 (1983).
Google Scholar
Segura, Á. et al. Preclinical evaluation of the efficacy of a brand new antivenom (EchiTAb-Plus-ICP®) for the therapy of viper envenoming in sub-Saharan Africa. Toxicon 55, 369–374 (2010).
Google Scholar
Ho, C. H. et al. Analysis of the necrosis-inducing elements of the venom of Naja atra and evaluation of the neutralization skill of freeze-dried antivenom. Toxins 13, 1–12 (2021).
Google Scholar
Knudsen, C. et al. Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy. Toxins 12, 528 (2020).
Google Scholar
Nerella, N. G., Block, L. H. & Noonan, P. Ok. The Impact of Lag Time on the Estimation of Pharmacokinetic Parameters. I. One-Compartment Open Model. Pharm. Res. 10, 1031–1036 (1993).
Google Scholar
Dockrell, H. M. & Smith, S. G. What have we learnt about BCG vaccination within the final 20 years? Frontiers in Immunology 8, 1134 (2017).
Bashorun, A. O. et al. Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a marketing campaign: a realistic, open-label, non-inferiority trial in The Gambia. Lancet Glob. Health 10, e257–e268 (2022).
Google Scholar
Zhong, H., Chan, G., Hu, Y., Hu, H. & Ouyang, D. A Comprehensive Map of FDA-Approved Pharmaceutical Products. Pharmaceutics 10, 1–19 (2018).
Google Scholar
Baryakova, T. H., Pogostin, B. H., Langer, R. & McHugh, Ok. J. Overcoming boundaries to affected person adherence: the case for growing modern drug supply programs. Nat. Rev. Drug Discov. 22, 387–409 (2023).
Google Scholar
Ogunfowokan, O. Bite-to-hospital time and morbidity in victims of viper chew in a rural hospital in Nigeria. Afr. J. Prim Health Care Fam Med. 4, 1–7 (2012).
Google Scholar
Sharma, N., Chauhan, S., Faruqi, S., Bhat, P. & Varma, S. Snake envenomation in a north Indian hospital. Emerg. Med. J. 22, 118–120 (2005).
Google Scholar
Abouyannis, M. et al. A protracted-term observational research of paediatric snakebite in Kilifi County, south-east Kenya. PLOS Negl. Trop. Dis. 17, e0010987 (2023).
Kazandjian, T. et al. Convergent evolution of defensive venom elements in spitting cobras. Science 371, 386–390 (2021).
Google Scholar
Shoichet, B. Ok. Interpreting steep dose-response curves in early inhibitor discovery. J. Med. Chem. 49, 7274–7277 (2006).
Google Scholar
Mora-Obando, D., Fernández, J., Montecucco, C., Gutiérrez, J. M. & Lomonte, B. Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo. PLoS One 9, 1–11 (2014).
Google Scholar
Pucca, M. B. et al. Unity makes power: exploring intraspecies and interspecies toxin synergism between phospholipases A2 and cytotoxins. Front. Pharmacol. 11, 1–10 (2020).
Google Scholar
Bustillo, S. et al. Phospholipase A2 enhances the endothelial cell detachment impact of a snake venom metalloproteinase within the absence of catalysis. Chem. Biol. Interact. 240, 30–36 (2015).
Google Scholar
Takeda, S., Takeya, H. & Iwanaga, S. Snake venom metalloproteinases: construction, perform and relevance to the mammalian ADAM/ADAMTS household proteins. Biochim. Biophys. Acta. 1824, 164–176 (2012).
Google Scholar
Beckett, R. P., Davidson, A. H., Drummond, A. H., Huxley, P. & Whittaker, M. Recent advances in matrix metalloproteinase inhibitor analysis. Drug Discov. Today 1, 16–26 (1996).
Google Scholar
Evans, J. D. et al. A part II trial of marimastat in superior pancreatic most cancers. Br. J. Cancer 85, 1865–1870 (2001).
Google Scholar
Menzies, S. Ok. et al. In vitro and in vivo preclinical venom inhibition assays establish metalloproteinase inhibiting medication as potential future remedies for snakebite envenoming by Dispholidus typus. Toxicon X 14, 1–10 (2022).
Google Scholar
Chowdhury, A. et al. Venom-induced blood disturbances by palearctic viperid snakes, and their relative neutralization by antivenoms and enzyme-inhibitors. Front. Immunol. 12, 1–14 (2021).
Google Scholar
Warrell, D. A. & Arnett, C. The significance of bites by the noticed scaled or carpet viper (Echis carinatus): epidemiological research in Nigeria and a evaluation of the world. Acta Trop. 33, 307–341 (1976).
Google Scholar
Amr, Z. S., Abu Baker, M. A. & Warrell, D. A. Terrestrial venomous snakes and snakebites within the Arab international locations of the Middle East. Toxicon 177, 1–15 (2020).
Warrell, D. A. et al. Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Quart. J. Med. 46, 33–62 (1977).
Google Scholar
Sasa, M. & Segura Cano, S. E. New insights into snakebite epidemiology in Costa Rica: a retrospective analysis of medical data. Toxicon X 7, 1–12 (2020).
Google Scholar
Otero, R. et al. Complications of Bothrops, Porthidium, and Bothriechis snakebites in Colombia. A scientific and epidemiological research of 39 circumstances attended in a college hospital. Toxicon 40, 1107–1114 (2002).
Google Scholar
Cruz, N. S. & Alvarez, R. G. Rattlesnake chew issues in 19 youngsters. Pediatr. Emerg. Care 10, 30–33 (1994).
Google Scholar
Maxmen, A. The struggle to fabricate COVID vaccines in lower-income international locations. Nature 597, 455–457 (2021).
Google Scholar
Pilkington, V., Keestra, S. M. & Hill, A. Global COVID-19 vaccine inequity: failures within the first 12 months of distribution and potential options for the long run. Front. Public Health 10, 1–8 (2022).
Google Scholar
Tilbury, C. R. Observations on the chew of the Mozambique spitting cobra (Naja mossambica mossambica). S. Afr. Med. J. 61, 308–313 (1982).
Google Scholar
Abouyannis, M. et al. TRUE-1: trial of repurposed Unithiol for snakebite envenoming part 1 (security, tolerability, pharmacokinetics and pharmacodynamics in wholesome Kenyan adults). Wellcome Open Res. 7, 1–33 (2022).
Google Scholar
Issa, M. E. et al. Jadomycins are cytotoxic to ABCB1-, ABCC1-, and ABCG2-overexpressing MCF7 breast most cancers cells. Anticancer Drugs 25, 255–269 (2014).
Google Scholar
Jaykaran. ‘Mean SEM’ or ‘mean (SD)’. Indian J. Pharmacol. 42, 1–1 (2010).
Lazic, S. E., Clarke-Williams, C. J. & Munafò, M. R. What precisely is ‘N’ in cell tradition and animal experiments? PLoS Biol. 16, 1–14 (2018).
Google Scholar
Hall, S. R. Histopathology photographs for Hall, et al., 2022. figshare https://doi.org/10.6084/m9.figshare.19706761.v1 (2022).
